Cargando…

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis

BACKGROUND: Antimicrobial stewardship is a systematic effort to change prescribing attitudes that can provide benefit in the provision of care to persons with cystic fibrosis (CF). Our objective was to decrease the unwarranted use of broad‐spectrum antibiotics and assess the impact of an empiric ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennedy, Charles, Greenberg, Isabella, Perez, Geovanny F., Chaney, Hollis, Sami, Iman, Ogunlesi, Folasade, Koumbourlis, Anastassios C., Hammer, Benjamin, Hamdy, Rana F., Cogen, Jonathan D., Payne, Asha S., Hahn, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305469/ https://www.ncbi.nlm.nih.gov/pubmed/35084122 http://dx.doi.org/10.1002/ppul.25840

Ejemplares similares

2573. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Lung Microbiome Diversity and Pulmonary Function
por: Jason. Bozzella, Michael, et al.
Publicado: (2019)

Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation
por: Inam, Zaina, et al.
Publicado: (2022)

Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids
por: Felton, Erin, et al.
Publicado: (2021)

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
por: Hahn, Andrea, et al.
Publicado: (2020)

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2021)

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
por: Shumyatsky, Gabriella, et al.
Publicado: (2023)

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2019)

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
por: Hahn, Andrea, et al.
Publicado: (2020)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

2578. Trends in Pathogens and Antibiotic Treatment in Children with Cystic Fibrosis in 2018 and 2022: A Retrospective Multicenter Study
por: Stout, Dayna, et al.
Publicado: (2023)

AtbFinder Diagnostic Test System Improves Optimal Selection of Antibiotic Therapy in Persons with Cystic Fibrosis
por: Tetz, G., et al.
Publicado: (2023)

Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis
por: de Almeida, Marina B., et al.
Publicado: (2010)

Big data analytics capability and co-innovation: An empirical study
por: Lozada, Nelson, et al.
Publicado: (2019)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Ozone Is Associated With an Increased Risk of Respiratory Exacerbations in Patients With Cystic Fibrosis
por: Farhat, Sylvia C.L., et al.
Publicado: (2013)

Post-thyroidectomy hypocalcemia exacerbated by chyle leak
por: Alzaman, Naweed, et al.
Publicado: (2015)

25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis
por: Hergenroeder, G., et al.
Publicado: (2021)

Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients
por: Fanous, Hani K., et al.
Publicado: (2018)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
por: Wells, J. Michael, et al.
Publicado: (2016)

Pulmonary dysfunction among adolescents and adults with sickle cell disease in Nigeria: Implications for monitoring
por: Ozoh, Obianuju B., et al.
Publicado: (2019)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis
por: Lavie, Moran, et al.
Publicado: (2011)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Daily spirometry in an acute exacerbation of adult cystic fibrosis patients
por: Stephen, Michael J, et al.
Publicado: (2017)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Virus and cystic fibrosis: Rhinoviruses are associated with exacerbations in adult patients()
por: Goffard, Anne, et al.
Publicado: (2014)

Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
por: Pribble, Charles G., et al.
Publicado: (1990)

Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis
por: Spoletini, Giulia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6g7hkeagul069a42720vs0f959